These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 34585382)
21. The potential role of follicular helper T cells in idiopathic multicentric Castleman disease with and without TAFRO syndrome. Kurose N; Guo X; Shioya A; Mizutani KI; Kumagai M; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Nakamura S; Yamada S Pathol Res Pract; 2019 Oct; 215(10):152563. PubMed ID: 31358479 [TBL] [Abstract][Full Text] [Related]
22. Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Fajgenbaum DC Blood; 2018 Nov; 132(22):2323-2330. PubMed ID: 30487129 [TBL] [Abstract][Full Text] [Related]
23. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology. Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113 [TBL] [Abstract][Full Text] [Related]
24. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease. Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567 [TBL] [Abstract][Full Text] [Related]
25. Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients. Ducoux G; Guerber A; Durel CA; Asli B; Fadlallah J; Hot A Am J Case Rep; 2020 Apr; 21():e919536. PubMed ID: 32249274 [TBL] [Abstract][Full Text] [Related]
26. Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease. Bustamante MS; Pierson SK; Ren Y; Bagg A; Brandstadter JD; Srkalovic G; Mango N; Alapat D; Lechowicz MJ; Li H; Van Rhee F; Lim MS; Fajgenbaum DC Haematologica; 2024 Jul; 109(7):2196-2206. PubMed ID: 38205523 [TBL] [Abstract][Full Text] [Related]
27. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature. Zhou Q; Zhang Y; Zhou G; Zhu J BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930 [TBL] [Abstract][Full Text] [Related]
31. TAFRO syndrome: 2 cases and review of the literature. Kawashima M; Usui T; Okada H; Mori I; Yamauchi M; Ikeda T; Kajita K; Kito Y; Miyazaki T; Fujioka K; Ishizuka T; Morita H Mod Rheumatol; 2017 Nov; 27(6):1093-1097. PubMed ID: 26052800 [TBL] [Abstract][Full Text] [Related]
32. Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging. Nara M; Komatsuda A; Itoh F; Kaga H; Saitoh M; Togashi M; Kameoka Y; Wakui H; Takahashi N Intern Med; 2017; 56(10):1247-1252. PubMed ID: 28502946 [TBL] [Abstract][Full Text] [Related]
34. Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study. Zhang Y; Suo SS; Yang HJ; Zhou XP; You LS; Yu WJ; Wang ZM; Jin J J Cancer Res Clin Oncol; 2020 Feb; 146(2):357-365. PubMed ID: 31938902 [TBL] [Abstract][Full Text] [Related]
35. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity? Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138 [TBL] [Abstract][Full Text] [Related]
36. Exploring the role of insulin-like growth factor binding protein-1 in identifying idiopathic multicentric Castleman's disease types: Implications for the mTOR signaling pathway. Sumiyoshi R; Koga T; Fukui S; Furukawa K; Momoki M; Ichinose K; Yano S; Kawakami A Clin Immunol; 2023 Nov; 256():109798. PubMed ID: 37778714 [TBL] [Abstract][Full Text] [Related]
37. Idiopathic Plasmacytic Lymphadenopathy Forms an Independent Subtype of Idiopathic Multicentric Castleman Disease. Nishikori A; Nishimura MF; Nishimura Y; Otsuka F; Maehama K; Ohsawa K; Momose S; Nakamura N; Sato Y Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142213 [TBL] [Abstract][Full Text] [Related]
38. Delayed diagnosis of TAFRO syndrome: A case report. Qiao Y; Zhang X; Xu R; Jia X; Wang Q Medicine (Baltimore); 2024 Aug; 103(31):e39148. PubMed ID: 39093747 [TBL] [Abstract][Full Text] [Related]
39. Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Fajgenbaum DC Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):318-325. PubMed ID: 30504327 [TBL] [Abstract][Full Text] [Related]
40. Computed tomography findings of early-stage TAFRO syndrome and associated adrenal abnormalities. Kurokawa R; Gonoi W; Yokota H; Isshiki S; Ohira K; Mizuno H; Kiguchi T; Inui S; Kurokawa M; Kato S; Matsuki M; Takeda T; Yokoyama K; Ota Y; Nakai Y; Maeda E; Mori H; Abe O Eur Radiol; 2020 Oct; 30(10):5588-5598. PubMed ID: 32440781 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]